KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Minority Interest (2016 - 2026)

Gsk has reported Minority Interest over the past 18 years, most recently at -$579.7 million for Q1 2026.

  • For Q1 2026, Minority Interest rose 8.49% year-over-year to -$579.7 million; the TTM value through Mar 2026 reached -$579.7 million, up 8.49%, while the annual FY2025 figure was -$560.0 million, 25.42% up from the prior year.
  • Minority Interest for Q1 2026 was -$579.7 million at Gsk, down from -$560.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $8.7 billion in Q1 2022 and troughed at -$775.1 million in Q1 2024.
  • A 5-year average of $407.5 million and a median of -$617.5 million in 2023 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: tumbled 108.44% in 2023 and later increased 25.9% in 2025.
  • Year by year, Minority Interest stood at -$588.8 million in 2022, then fell by 16.36% to -$685.1 million in 2023, then fell by 9.59% to -$750.8 million in 2024, then rose by 25.42% to -$560.0 million in 2025, then dropped by 3.52% to -$579.7 million in 2026.
  • Business Quant data shows Minority Interest for GSK at -$579.7 million in Q1 2026, -$560.0 million in Q4 2025, and -$534.3 million in Q3 2025.